Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3422]
News [7838]
Articles [63]
Editorials [9]
Conferences [210]
elearning [49]
FLIMS workshop and management of triple negative breast cancer
Dr Margaret Hutka - Royal Marsden Hospital, London, UK
FLIMS workshop and management of triple negative breast cancer ( Dr Margaret Hutka - Royal Marsden Hospital, London, UK )
30 Mar 2012
ECCO and cancer care in Europe
Prof Cornelis van de Velde - President of ECCO
ECCO and cancer care in Europe ( Prof Cornelis van de Velde - President of ECCO )
29 Mar 2012
Managing HER2 overexpression in breast cancer
Prof Michael Untch - Helios Clinic, Berlin, Germany
Managing HER2 overexpression in breast cancer ( Prof Michael Untch - Helios Clinic, Berlin, Germany )
29 Mar 2012
Debate on the success of breast cancer screening programmes
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Debate on the success of breast cancer screening programmes ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
24 Mar 2012
Analysis of thirty years of clinical trial data
Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK
Analysis of thirty years of clinical trial data ( Prof Richard Peto - Clinical Trial Service Unit, Oxford University, UK )
23 Mar 2012
Recent advances in multiple myeloma therapy
Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios...
Recent advances in multiple myeloma therapy ( Prof San Miguel, Prof Philippe Moreau, Prof Antonio Palumbo, Prof Meletios Dimopoulos and Prof Thierry Facon )
14 Feb 2012
Recent advances in non-Hodgkin’s lymphoma therapy
Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter
Recent advances in non-Hodgkin’s lymphoma therapy ( Prof Mathias Rummel, Prof Umberto Vitolo, Prof Georg Hess, Prof Finbarr Cotter )
14 Feb 2012
What drives improvements in cancer care?
Prof Kurt Miller, Prof Gordon McVie, Dr Karim Fizazi, Peter Hazenberg, Jane...
What drives improvements in cancer care? ( Prof Kurt Miller, Prof Gordon McVie, Dr Karim Fizazi, Peter Hazenberg, Jane Griffiths )
13 Jan 2012
BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory...
Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston
BTK inhibitor PCI-32765 induces durable responses in relapsed or refractory chronic lymphocytic leukaemia/small lymphocytic lymphoma ( Prof Susan O’Brien - University of Texas MD Anderson Cancer Center, Houston )
9 Jan 2012
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell...
Dr Laurie Sehn - University of British Columbia, Vancouver, Canada
Obinutuzumab with rituximab in patients with relapsed CD20 and indolent B-Cell non-hodgkin lymphoma (GAUSS) ( Dr Laurie Sehn - University of British Columbia, Vancouver, Canada )
9 Jan 2012
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma
Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group
ABVD chemo with radiation therapy for limited-stage hodgkin lymphoma ( Dr Ralph Meyer - National Cancer Institute of Canada Clinical Trials Group )
9 Jan 2012
Two rituximab dosing strategies for low tumour burden follicular lymphoma...
Prof Brad Kahl - University of Wisconsin, Madison, USA
Two rituximab dosing strategies for low tumour burden follicular lymphoma (RESORT) ( Prof Brad Kahl - University of Wisconsin, Madison, USA )
9 Jan 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation